Skip to main content

and
  1. Article

    Open Access

    Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)

    Surgical sentinel lymph node biopsy (SLNB) is routinely used to reliably stage axillary lymph nodes in early breast cancer (BC). However, SLNB may be associated with postoperative arm morbidities. For most pat...

    Ida Skar**, Julia Ellbrant, Looket Dihge, Mattias Ohlsson, Linnea Huss in BMC Cancer (2024)

  2. Article

    Open Access

    The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer

    The need for sentinel lymph node biopsy (SLNB) in clinically node-negative (cN0) patients is currently questioned. Our objective was to investigate the cost-effectiveness of a preoperative noninvasive lymph no...

    Ida Skar**, Kristoffer Nilsson, Looket Dihge in Breast Cancer Research and Treatment (2022)

  3. Article

    Open Access

    Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer

    High-performing imaging and predictive markers are warranted to minimize surgical overtreatment of the axilla in breast cancer (BC) patients receiving neoadjuvant chemotherapy (NACT). Here we have investigated...

    Ida Skar**, Daniel Förnvik, Sophia Zackrisson in Breast Cancer Research and Treatment (2021)

  4. Article

    Open Access

    Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients

    Personalized cancer treatment requires predictive biomarkers, including image-based biomarkers. Breast cancer (BC) patients receiving neoadjuvant chemotherapy (NACT) are in a clinically vulnerable situation wi...

    Ida Skar**, Daniel Förnvik, Uffe Heide-Jørgensen, Hanna Sartor in Cancer Causes & Control (2021)

  5. Article

    Open Access

    Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

    Our aim is to study if mammographic density (MD) prior to neoadjuvant chemotherapy is a predictive factor in accomplishing a pathological complete response (pCR) in neoadjuvant-treated breast cancer patients.

    Ida Skar**, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen in BMC Cancer (2019)

  6. Article

    Open Access

    Effects of statin use on volumetric mammographic density: results from the KARMA study

    Epidemiological data on statins and breast cancer risk have been inconclusive. The aim of this study was to clarify the role of statins in breast cancer risk by studying their effect on mammographic density.

    Ida Skar**, Judith S. Brand, Per Hall, Signe Borgquist in BMC Cancer (2015)